Application of continuous stirred membrane reactor to 3-cyanopyridine bioconversion using the nitrile hydratase-amidase cascade system of Microbacterium imperiale CBS 498-74

Enzyme and Microbial Technology

Volumn 47, Issue 3, 2010, Pages 64-70

  Cantarella, L ^b   Gallifuoco, A ^a   Malandra, A ^a   Martinkova L ^c   Pasquarelli, F ^a   Spera, A ^a   Cantarella, M ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

3 Cyanopyridine bioconversion; Continuous stirred membrane reactor; Nicotinamide; Nicotinic acid; Nitrile hydratase amidase cascade system

Indexed keywords

3-CYANOPYRIDINE; 3-CYANOPYRIDINE BIOCONVERSION; AMIDASE; CASCADE SYSTEMS; MEMBRANE REACTOR; NICOTINIC ACID; NITRILE HYDRATASES;

ACIDS; AMIDES; BIOCONVERSION; BIOREACTORS; ELECTRIC CIRCUIT BREAKERS; ENZYME ACTIVITY; ENZYMES; SUBSTRATES; ULTRAFILTRATION;

CYANIDES;

AMIDASE; ENZYME; NICOTINIC ACID; NICOTINONITRILE; NITRILE HYDRATASE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOCATALYST; BIOTRANSFORMATION; BREVIBACTERIUM; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTINUOUS STIRRED TANK REACTOR; CONTROLLED STUDY; EFFLUENT; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; FLOW RATE; MEAN RESIDENCE TIME; MEMBRANE REACTOR; MICROBACTERIUM IMPERIALE; NONHUMAN; ULTRAFILTRATION;

MICROBACTERIUM IMPERIALE;

EID: 77954660755     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2010.05.009     Document Type: Article

References (21)

1. Bogan L.K., Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 2008, 28:115-130.
2. Pero R.W., Axelsson B., Siemann D., Chaplin D., Dougherty G. Newly discovered anti-inflammatory properties of the benzamides and nicotinamides. Mol Cell Biochem 1999, 193:119-123.
3. Bingley P.J., Mahon J.L., Gale E.A. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 2008, 31:146-150.
4. Ungerstedt J.S., Blomback M., Soderstrom T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 2003, 131:48-52.
5. McCarty M.F., Russell A.L. Niacinamide therapy for osteoarthritis-does it inhibit nitric oxide synthase induction by interleukin 1 in chondrocytes?. Med Hypotheses 1999, 53:350-360.
6. Meyers C.D., Liu P., Kamanna V.S., Kashyap M.L. Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush. Atherosclerosis 2007, 192:253-258.
7. Yang J., Adams J.D. Nicotinamide and its pharmacological properties for clinical therapy. Drug Design Rev (Bentham Science Publishers - Online) 2004, 1(10):43-52.
8. Moëll A., Skog O., Ahlin E., Korsgren O., Frisk G. Antiviral effect of nicotinamide on enterovirus-infected human islets in vitro: effect on virus replication and chemokine secretion. J Med Virol 2009, 81:1082-1087.
9. Nagasawa T., Mathew C.D., Mauger J., Yamada H. Nitrile hydratase catalyzed production of nicotinamide from 3-cyanopyridine in Rhodococcus rhodochrous J1. Appl Environ Microbiol 1988, 54:1766-1769.
10. Chuck R. Technology development in nicotinate production. Appl Catal A: Gen 2005, 280:75-82.
11. Kaplan O., Nikolaou K., Pišvejcová A., Martínková L. Hydrolysis of nitriles and amides by filamentous fungi. Enzyme Microb Technol 2006, 38:260-264.
12. Kaplan O., Vejvoda V., Charvátová-Pišvejcová A., Martínková L. Hyperinduction of nitrilases in filamentous fungi. J Ind Microbiol Biotechnol 2006, 33:891-896.
13. Martínková L., Vejvoda V., Kaplan O., Křen V., Bezouška K., Cantarella M. Nitrilases from filamentous fungi. Modern biocatalysis stereoselective and environmentally friendly reactions 2009, 229-245. Wiley-VCH Verlag GmH & Co. KGaA, Weinheim, [Chapter 14]. W.D. Fessner, T. Anthonsen (Eds.).
14. Yamada H., Kobayashi M. Nitrile hydratase and its application to industrial production of acrylamide. Biosci Biotechnol Biochem 1996, 60:1391-1400.
15. Wyatt J.M., Knowles C.J. The development of a novel strategy for the microbial treatment of acrylonitrile effluents. Biodegradation 1995, 6:93-107.
16. Cantarella M., Cantarella L., Spera A., Alfani F. Acrylamide production in an ultrafiltration-membrane bioreactor using cells of Brevibacterium imperialis CBS 489-74. J Membr Sci 1998, 147:279-290.
17. Cantarella M., Cantarella L., Gallifuoco A., Frezzini R., Spera A., Alfani F. A study in UF-membrane reactor on activity and stability of nitrile hydratase from Microbacterium imperiale CBS 498-74 resting cells for propionamide production. J Mol Catal B-Enzym 2004, 29:105-113.
18. Cantarella M., Cantarella L., Gallifuoco A., Spera A. Use of a UF-membrane reactor for controlling selectively the nitrile hydratase-amidase system in Microbacterium imperiale CBS 498-74 resting cells-case study: benzonitrile conversion. Enzyme Microb Technol 2006, 38:126-134.
19. Cantarella M., Gallifuoco A., Spera A., Cantarella L., Kaplan O., Martínková L. UF-membrane bioreactors for kinetics characterization of nitrile hydratase-amidase catalyzed reactions: a short survey. Modern biocatalysis stereoselective and environmentally friendly reactions 2009, 273-286. Wiley VCH Verlag GmH & Co. KGaA, Weinheim, [Chapter 17]. W.D. Fessner, T. Anthonsen (Eds.).
20. Cantarella M., Cantarella L., Gallifuoco A., Intellini R., Kaplan O., Spera A., et al. Amidase-catalyzed production of nicotinic acid in batch and continuous stirred membrane reactors. Enzyme Microb Technol 2008, 42:222-229.
21. Alfani F., Cantarella M., Spera A., Viparelli P. Operational stability of Brevibacterium imperialis CBS 489-74 nitrile hydratase. J Mol Catal B-Enzym 2001, 11:687-697.